Te mōhiotanga me te tūtei i ngā mate hōrapa
Infectious disease intelligence & surveillance
We provide intelligence on notifiable diseases and other serious health threats, such as influenza and antimicrobial resistance.
About
About
ESR undertakes surveillance of notifiable diseases in New Zealand and manages the national notifiable disease database (EpiSurv) on behalf of the Ministry of Health. You can read more about EpiSurv on our health information systems page.
The purpose of surveillance is to provide information for action. Information provided by regular surveillance reports enables effective monitoring of rates and distribution of diseases, detection of outbreaks, monitoring of interventions, predicting emerging hazards, and diseases linked with climate change.
This webpage hosts all our public-facing surveillance reports and dashboard about key infectious diseases in Aotearoa New Zealand. Reports include analyses and interpretation of surveillance data, primarily for notifiable diseases, influenza and sexually transmitted infections. See below our monthly and annual surveillance reports, annual summary tables (tier 1 statistics) and reports grouped by key focus topics.
We currently publish six main dashboards with regular updates to data:
- Measles and pertussis dashboards are updated weekly.
- The respiratory illness dashboard is updated weekly during the winter season and at least monthly in summer.
- The Meningococcal disease dashboard is updated monthly.
- The invasive pneumococcal disease (IPD) dashboard is updated monthly
- The main STI dashboard is updated quarterly, and we also publish an annual version each calendar year.
- The notifiable disease dashboard is updated annually.
Visit our methodologies page to learn more about what goes on behind some of our dashboards.
Surveillance reports
Notifiable disease dashboard
Monthly notifiable disease surveillance report October 2024
Monthly notifiable disease surveillance report September 2024
Monthly notifiable disease surveillance report August 2024
Monthly notifiable disease surveillance report July 2024
Monthly notifiable disease surveillance report June 2024
Notifiable diseases annual surveillance summary 2022
This report provides a summary of the key trends in notifiable diseases for 2022.
Monthly notifiable disease surveillance report May 2024
Monthly notifiable disease surveillance report April 2024
Monthly notifiable disease surveillance report March 2024
Monthly notifiable disease surveillance report February 2024
Monthly notifiable disease surveillance report January 2024
2023 Annual summary tables notifiable diseases tier 1 statistics
Notifiable diseases annual surveillance summary 2021
This report provides a summary of the key trends in notifiable diseases for 2021.
Notifiable diseases annual surveillance summary 2020
This report provides a summary of the key trends in notifiable diseases for 2020.
Find our surveillance reports on these focus topics:
Respiratory illness / Influenza
Sexually transmitted infections (STIs)
COVID-19
Notifiable disease reports
Measles
Meningococcal disease
Pertussis
Invasive pneumococcal disease (IPD)
Invasive group A streptococcal infection
Tuberculosis
Human salmonella isolates
Non-human salmonella isolates
Yersinia isolates
Vibrio isolates
Shigella isolates
STEC/VTEC isolates
We welcome the use of our surveillance data with the following acknowledgement:
New Zealand surveillance data provided by ESR, funded by the Ministry of Health with the cooperation of the diagnostic laboratories.
Resources
Useful resources
Guidelines for the investigation and control of disease outbreaks
Check the schedule of notifiable diseases for New Zealand
Communicable disease control manual (Te Whatu Ora)
Methodologies - STI, ILI and EARS
GP resources for the influenza-like-illness (ILI) programme
Guidelines for notification messaging and systems, see Te Whatu Ora's laboratory information standards
Notifiable disease FAQs
EpiSurv case report forms
How to report a notifiable disease
How to report a notifiable disease
Instructions for notifiable diseases not reported through Episurv
AIDS and HIV
Gonorrhoea
Click here for the link to the case definition for gonorrhoea.
Health practitioners, please notify cases of gonorrhoea via ESR's web-based REDCap form. Follow these instructions to complete the REDCap 'quesionnaire'.
An example copy of the gonorrhoea notification form is available for health practitioners to preview the questions before beginning the online notification process: view an example
Please note: ESR does not accept paper-based notifications for gonorrhoea. Case notifications must be completed online via the REDCap form.
Syphilis
Click here for the link to the New Zealand CDC Manual case definition for syphilis. Note that late latent and tertiary syphilis are not notifiable.
The majority of infectious syphilis cases are notified by sexual health clinics who have access to a web-based REDCap database to input their data directly. Click here to view the REDCap instructions for sexual health clinics.
Health practitioners working outside sexual health clinics who diagnose infectious or congenital syphilis cases are required to complete a notification form and send it to ESR for entry into REDCap (further instructions are in the form). Please select the appropriate form below.
Infectious Syphilis Notification Form
Congenital Syphilis Notifcation Form
Clinic and laboratory-based STI surveillance
Click here to view the STI case definitions for clinic-based surveillance.
Participating clinics send anonymised data on the age, sex and ethnicity of all cases meeting one or more of the STI surveillance case definitions to ESR.
Likewise, each month participating laboratories across New Zealand send anonymised data on confirmed cases of chlamydia and gonorrhoea by age and sex, to ESR. Laboratories also provide the total number of specimens and/or patients tested.
After checking and cleaning the data, ESR produces a quarterly and annual dashboard and annual reports with all data reported during the previous year.
FAQs
Frequently asked questions
Which diseases are notifiable in New Zealand?
The current list of notifiable diseases can be found on the Ministry of Health website.
Case classifications (including laboratory and clinical criteria) for notifiable diseases and/or conditions are published in the Communicable Disease Control Manual. Trigger points for the notification of a laboratory test result are detailed in Appendix 4.
Which notifiable diseases are reported by ESR?
ESR reports on all notifiable diseases except the following:
- Creutzfeldt-Jakob disease (CJD) and other spongiform encephalopathies
- Human Immunodeficiency Virus (HIV) infection
- lead absorption equal to or in excess of 0.24µmol/L
- poisoning arising from chemical contamination of the environment.
Where can I find out more information about specific diseases?
For a summary of notification procedures, design and collection methods, quality control and editing procedures, and information specific to each disease, see the latest edition of the Notifiable Diseases in New Zealand Annual Report.
What data is collected for notifiable diseases?
The data collected depends on the disease, but generally include case demography, health outcome, basis of diagnosis, risk factors and some clinical management information. Copies of the case report forms for each disease are loaded on the EpiSurv help site, as well as instructions for which form to use.
How is notifiable disease data collected and reported?
Under the Health Act 1956, health professionals are required to inform their local Medical Officer of Health of any suspected or diagnosed notifiable disease. Laboratories are also required to report any positive laboratory results for notifiable diseases to their local Medical Officer of Health.
Notifiable disease data reported to the Medical Officer of Health at each public health unit (PHU) is entered via a secure web-based portal into the EpiSurv national database. The near real-time data is collated and analysed by the Institute of Environmental Science and Research Ltd (ESR) on behalf of the Ministry of Health.
View a flowchart of this process.
What quality processes are applied to the data collection and reporting?
ESR runs a comprehensive quality programme for the collection and reporting of notifiable disease data. This includes publishing and maintaining standards and manuals for reporting of disease, validation on data entry, regular analysis and follow-up with PHU staff to ensure completeness of key surveillance data fields (e.g. date of birth, sex, and ethnicity).
Where can I find reports that include notifiable disease data?
Regular surveillance reports on notifiable diseases are produced by the Institute of Environmental Science and Research Ltd (ESR) for the Ministry of Health as part of a contract for scientific services.
The latest published data and reports can be found in the digital library under expertise area 'Public Health'
When is the next release of notifiable disease statistics due?
Tier 1 statistical tables are released at the end of February each year for the calendar year prior. Annual notifiable disease reports are due for publication by December for the calendar year prior and the data tables contained in the reports replace the Tier 1 statistics. The annual notifiable disease dashboard is updated around July each year and can be found here.
Why is the number of historical cases published in this year’s report different to the numbers previously published?
As EpiSurv is a live database, data is extracted at a point in time that reflects the available information at that time. Every effort is made prior to publication to ensure that any anomalies and missing data are addressed. However, data extracted at a later date may be different to the data that was previously published. If a report includes historical data, this is updated each time a new report is published.
For most diseases, the case classification and investigations are finalised within one month. However, for some notifiable diseases (e.g. tuberculosis or legionellosis) it may take longer to obtain complete laboratory tests or all relevant clinical details. If the classification for a case is changed to ‘not a case’), the case will excluded from future reports.
What role does ESR have in outbreak surveillance?
Disease outbreaks are increases in the occurrence of a disease in excess of normally expected levels. Outbreaks are often related to contaminated food or water, or to illnesses spread from person to person. Every year, hundreds of people in New Zealand become unwell due to disease outbreaks, most of which are preventable.
The Institute of Environmental Science and Research Limited (ESR) has a central role in outbreak surveillance. This work includes:
- Regular analysis of notification, laboratory and other surveillance data to identify disease outbreaks early and minimise further spread of disease.
- Operation of an outbreak surveillance system on behalf of the Ministry of Health. Outbreaks reported to, and investigated by, public health units are recorded on the outbreak report form in EpiSurv. This data is a resource for multiple agencies seeking to understand local and national patterns of disease in New Zealand and develop strategies for disease outbreak prevention. Information about outbreaks is reported in the monthly and annual surveillance summaries.
- Publication of the Guidelines for the surveillance and control of disease outbreaks to assist action at district or national level by streamlining particular processes according to a set routine or sound practice.
- ESR provides advice on outbreak detection and investigation to public health unit staff.
- ESR may contribute to and coordinate the investigation of, disease outbreaks of national importance, particularly those involving more than one health district.
What is EARS?
EARS is an Early Aberration Reporting System. You can find more information and methodology on our methodologies page.
Where can I get further information if I still have questions?
If you need further information about notifiable diseases please contact our health intelligence and surveillance team.